The present invention is directed to the polymorphic Form B and the amorphous form of Benazepril hydrochloride. The present invention is also directed to processes for the preparation of Form B and the amorphous form of Benazepril hydrochloride, as well as novel processes for the preparation of Form A. Furthermore, the present invention is directed to pharmaceutical compositions comprising these crystalline forms.
本发明涉及
盐酸贝那普利的多晶型 B 和无定形形式。本发明还涉及制备
盐酸贝那普利的形式 B 和无定形形式的工艺,以及制备形式 A 的新工艺。此外,本发明还涉及包含这些结晶形式的药物组合物。